文献速递睡眠呼吸障碍咽喉与嗓音

全静脉麻醉缩短阻塞性睡眠呼吸暂停患者气道手术恢复时间

Reduced Recovery Times with Total Intravenous Anesthesia in Patients with Obstructive Sleep Apnea.
PubMed 文献 · Laryngoscope · 2020-11-03

这项回顾性研究纳入2019年接受上气道手术且合并阻塞性睡眠呼吸暂停的成人患者,比较全静脉麻醉与挥发性气体麻醉的恢复时间。结果显示全静脉麻醉组在麻醉恢复室第一阶段停留时间显著缩短,且缩短程度与手术类型和OSA严重程度相关。

要点

  • 全静脉麻醉较七氟烷气体麻醉显著缩短OSA患者上气道术后第一阶段恢复时间。
  • OSA严重程度越高,全静脉麻醉缩短恢复时间的优势越明显。
  • 不同上气道术式(鼻手术、上气道刺激、改良UPPP)均观察到恢复时间缩短。

核心结论

  • 合并OSA的上气道手术患者接受全静脉麻醉(丙泊酚联合瑞芬太尼)较七氟烷气体麻醉的第一阶段和总恢复室停留时间显著更短,且与OSA严重程度相关。

主要发现

  • 鼻手术、上气道刺激和改良悬雍垂腭咽成形术的全静脉麻醉组第一阶段恢复时间分别缩短35.5分钟(P < .001)、42.5分钟(P < .001)和36分钟(P = .022)。
  • 轻度、中度和重度OSA的全静脉麻醉组第一阶段恢复时间分别缩短23.5分钟(P = .004)、52分钟(P = .004)和47分钟(P < .001)。
  • 气体麻醉组OSA严重程度每增加一级,第一阶段时间增加16.8分钟(P < .001);全静脉麻醉组仅增加4.3分钟(P = .489)。

临床怎么用

  • 对于合并OSA接受上气道手术的患者,可优先考虑全静脉麻醉以缩短麻醉恢复室停留时间。
  • OSA严重程度较高的患者从全静脉麻醉中可能获益更大。

局限性

  • 回顾性研究设计,证据等级为3级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: There is currently no standard of care in terms of anesthesia modality for patients receiving upper airway surgery with comorbid obstructive sleep apnea (OSA). Although both total intravenous anesthesia (TIVA) and volatile gas anesthesia are commonly utilized in ambulatory otolaryngology surgery, it is currently unclear if there are any advantages with one modality over the other. We hypothesize that patients receiving upper airway surgery with comorbid OSA will have quicker recovery times with TIVA. STUDY DESIGN: Retrospective chart review from January 2019 to December 2019. METHODS: All patients aged 18 and older receiving upper airway surgery (upper airway stimulation, nasal surgery, modified uvulopalatopharyngoplasty) were included. Patients were excluded when there was incomplete or missing data in the electronic medical record. RESULTS: Eighty-six patients received gas anesthesia and 62 patients received TIVA. Phase I recovery times were significantly reduced by surgery and by severity of OSA: nasal surgery, upper airway stimulation, and modified uvulopalatopharyngoplasty had a reduction of 35.5 minutes (P < .001), 42.5 minutes (P < .001), and 36 minutes (P = .022), respectively. In terms of severity, mild, moderate, and severe OSA had reductions of 23.5 minutes (P = .004), 52 minutes (P = .004), and 47 minutes (P < .001), respectively. The severity of OSA generally correlated with increased time spent in Phase I: as severity increased, Phase I time increased by 16.8 minutes for the gas cohort (P < .001), whereas in the TIVA cohort, it increased only 4.3 minutes (P = .489). CONCLUSION: Patients having upper airway surgery with comorbid OSA that received TIVA (propofol and remifentanil) spent significantly less time in Phase I and the recovery room overall compared to those receiving volatile gas anesthesia in the form of sevoflurane, and this correlated with the severity of OSA. LEVEL OF EVIDENCE: 3. Laryngoscope, 131:925-931, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Stewart M, Estephan L, Thaler A, et al. Reduced Recovery Times with Total Intravenous Anesthesia in Patients with Obstructive Sleep Apnea. Laryngoscope. 2020. PMID: 33141982. doi:10.1002/lary.29216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。